Skip to main content

Table 1 Base Case Value and Sensitivity Range Used in the Model

From: Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model

• Transition probabilities

• Yearly base-case value (%)

• Range (%)

• Age-specific mortality

• 7.91 [27]

• –

• Rate of disease recurrence without worsening of the disease (LD group)

• 4.7 [10, 13] [25, 30]

• 3.99 [13]~ 7.05 [10]

• Rate of disease recurrence with worsening of the disease(LD group)

• 2.7 [10, 13] [25, 30]

• 2.06 [13]~ 5.98 [10]

• Rate of disease recurrence without worsening of the disease(FD group)

• 3.3 [4] [10, 26, 30]

• 1.55 [26] ~ 4.92 [4]

• Rate of disease recurrence with worsening of the disease(FD group)

• 3.7 [4] [10, 26, 30]

• 2.35 [26]~ 5.77 [10]

• Mortality of RC surgery

• 1.9 [31,32,33]

• 1 [33] ~ 5.2 [34]

• Metastatic rate after underwent RC

• 2.6 [35, 36]

• 2.3 [36] ~ 7.97[35]

• Death rate of metastatic state

• 44.1 [37]

• 42.99 [37] ~ 50 [38]